Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 1
1974 1
1975 1
1978 3
1979 1
1980 2
1981 1
1982 7
1983 2
1984 1
1985 4
1986 3
1987 5
1988 6
1989 3
1990 4
1991 8
1992 2
1993 3
1994 6
1995 5
1996 3
1997 4
1998 7
1999 5
2000 9
2001 8
2002 7
2003 9
2004 11
2005 10
2006 12
2007 15
2008 19
2009 18
2010 23
2011 20
2012 21
2013 24
2014 30
2015 27
2016 32
2017 25
2018 29
2019 24
2020 24
2021 33
2022 26
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

466 results
Results by year
Filters applied: . Clear all
Page 1
Cannabinoids and Pain: Sites and Mechanisms of Action.
Starowicz K, Finn DP. Starowicz K, et al. Among authors: finn dp. Adv Pharmacol. 2017;80:437-475. doi: 10.1016/bs.apha.2017.05.003. Epub 2017 Jun 20. Adv Pharmacol. 2017. PMID: 28826543 Review.
Mast cell stabilisers.
Zhang T, Finn DF, Barlow JW, Walsh JJ. Zhang T, et al. Among authors: finn df. Eur J Pharmacol. 2016 May 5;778:158-68. doi: 10.1016/j.ejphar.2015.05.071. Epub 2015 Jun 27. Eur J Pharmacol. 2016. PMID: 26130122 Review.
The cannabinoid system and pain.
Woodhams SG, Chapman V, Finn DP, Hohmann AG, Neugebauer V. Woodhams SG, et al. Among authors: finn dp. Neuropharmacology. 2017 Sep 15;124:105-120. doi: 10.1016/j.neuropharm.2017.06.015. Epub 2017 Jun 15. Neuropharmacology. 2017. PMID: 28625720 Free PMC article. Review.
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain.
Soliman N, Haroutounian S, Hohmann AG, Krane E, Liao J, Macleod M, Segelcke D, Sena C, Thomas J, Vollert J, Wever K, Alaverdyan H, Barakat A, Barthlow T, Bozer ALH, Davidson A, Diaz-delCastillo M, Dolgorukova A, Ferdousi MI, Healy C, Hong S, Hopkins M, James A, Leake HB, Malewicz NM, Mansfield M, Mardon AK, Mattimoe D, McLoone DP, Noes-Holt G, Pogatzki-Zahn EM, Power E, Pradier B, Romanos-Sirakis E, Segelcke A, Vinagre R, Yanes JA, Zhang J, Zhang XY, Finn DP, Rice ASC. Soliman N, et al. Among authors: finn dp. Pain. 2021 Jul 1;162(Suppl 1):S26-S44. doi: 10.1097/j.pain.0000000000002269. Pain. 2021. PMID: 33729209 Free PMC article.
PPARs and pain.
Okine BN, Gaspar JC, Finn DP. Okine BN, et al. Among authors: finn dp. Br J Pharmacol. 2019 May;176(10):1421-1442. doi: 10.1111/bph.14339. Epub 2018 Jun 3. Br J Pharmacol. 2019. PMID: 29679493 Free PMC article. Review.
466 results